These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 6127132

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats.
    Finberg JP, Tal A.
    Br J Pharmacol; 1985 Mar; 84(3):609-17. PubMed ID: 2985158
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M, Gorodetsky E, Wang RH, Gross A, Weinreb O, Youdim MB.
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of the blocking effect of alpha-adrenoceptor antagonist drugs towards directly and indirectly acting agonists on the rat vas deferens.
    Lucchelli A, Santagostino-Barbone MG, D'Agostino G, Grana E.
    Pharmacol Res Commun; 1983 Mar; 15(3):267-80. PubMed ID: 6134294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
    Hovevey-Sion D, Finberg JP.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monoamine oxidase B inhibition and the "cheese effect".
    Youdim MB, Finberg JP.
    J Neural Transm Suppl; 1987 Jul; 25():27-33. PubMed ID: 3480939
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
    Laporte J, Jané F, Valdecasas FG.
    J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
    [No Abstract] [Full Text] [Related]

  • 18. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
    Benedetti MS, Boucher T, Carlsson A, Fowler CJ.
    Biochem Pharmacol; 1983 Jan 01; 32(1):47-52. PubMed ID: 6830619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.
    Gal S, Abassi ZA, Youdim MB.
    Neurotox Res; 2010 Aug 01; 18(2):143-50. PubMed ID: 19894083
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.